ESR1 and breast carcinoma: On the contrary, PYK2 knockdown increased cell proliferation of SkBr3 and MDA-MB-453 cells, suggesting an antiproliferative function of PYK2 in HER2+/ER−/PR- breast cancer cell lines (Fig. 3c and d, Additional file 2: Figure S2).